TriSalus Life Sciences, Inc.
TLSIW- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001826667
No open-market purchases or sales by TriSalus Life Sciences, Inc. insiders were filed in the last 90 days; 5 institutions reported holding it in 13F filings for Q2 2026, worth $798.0K in total; no superinvestor holds it.
Other share classesTLSI
Q3 2023 vs. Q2 2023
How the institutions holding TriSalus Life Sciences, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 0 | 20 | +20 |
| Shares | 0 | 2.83M | +2.83M |
| Value | $0 | $1.20M | +$1.20M |
New holders (20)
Institutions that held TriSalus Life Sciences, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Magnetar Financial LLC | 879,509 | $330.9K | 0.01% |
| Highbridge Capital Management LLC | – | $136.8K | 0.01% |
| Deerfield Management Company, L.P. (Series C) | 333,333 | $126.7K | 0.00% |
| Polar Asset Management Partners Inc. | 285,864 | $108.6K | 0.00% |
| Exos TFP Holdings LLC | 167,610 | $63.7K | 0.03% |
| Kim, LLC | 167,566 | $63.0K | 0.01% |
| Vestcor Inc | 148,755 | $56.0K | 0.00% |
| MSD Partners, L.P. | 133,333 | $50.7K | 0.00% |
| Point72 Asset Management, L.P. | 133,333 | $50.7K | 0.00% |
| Walleye Capital LLC | 104,597 | $39.7K | 0.00% |
| Bracebridge Capital, LLC | 98,857 | $37.6K | 0.03% |
| Shaolin Capital Management LLC | 77,164 | $29.0K | 0.00% |
| Context Capital Management, LLC | 70,426 | $27.0K | 0.00% |
| Sequoia Financial Advisors, LLC | 62,187 | $23.6K | 0.00% |
| Cantor Fitzgerald, L. P. | 61,658 | $23.4K | 0.00% |
| CastleKnight Management LP | 46,371 | $17.4K | 0.00% |
| HRT Financial LP | 29,931 | $11.0K | 0.00% |
| Jane Street Group, LLC | 17,259 | $6.56K | 0.00% |
| Tower Research Capital LLC (TRC) | 42 | $16 | 0.00% |
| Nomura Holdings Inc | 10,800 | $0 | 0.00% |
Sold out (0)
Institutions that held TriSalus Life Sciences, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
None.